Oncology Clinical Trial Recruitment Drops Amid Coronavirus Pandemic

November 20, 2020

Oncology Clinical Trial Recruitment Drops Amid Coronavirus Pandemic

Enrollment in clinical trials for novel cancer drugs has reduced drastically since the start of the COVID-19 pandemic. This is due in part to a pause in recruitment on behalf of institutions to curb the spread of the virus as well as increased hesitation from patients themselves. Yourway has an extensive direct-to-patient program, eliminating the need for in-person trial visits, which aids in trial recruitment and retention.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Schedule a Meeting

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Schedule a Meeting

Media

Articles

Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials

Open chat

Hello! How can I help you?